Lungs News and Research

RSS

New Drug Application with the U.S. Food and Drug Administration for Tarceva

OSI Pharmaceuticals and Genentech have announced that OSI completed the submission of a New Drug Application with the U.S. Food and Drug Administration for Tarceva (erlotinib HCl),

3 Aug 2004

British Government’s failure to publish the long-promised TB Action Plan

Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government’s failure to publish the long-promised TB Action Plan.

3 Aug 2004

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Early intervention with a novel kind of "smart gene therapy" might effectively prevent the organ damage commonly suffered by heart attack victims, suggests a new animal study by researchers at Brigham and Women's Hospital in Boston and Duke University Medical Center.

2 Aug 2004

Computer-aided detection (CAD) can help physicians locate and analyze images from computed tomography (CT) scans

The diagnostic imaging modality of computed tomography (CT) scan is very helpful in lung cancer assessment as it spots even small lung tumors that might go undetected in conventional chest X-ray and other tests.

2 Aug 2004

Renal research boost for the University of Birmingham

The Medical School at the University of Birmingham is amongst four UK winners of the prestigious Genzyme Renal Innovations Programme (GRIP).

2 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Hormone that is important in the control of blood pressure may also inhibit the growth of lung cancer cells

Their studies found that angiotensin-(1-7) significantly slows the growth of three different types of human lung cancer cells in the laboratory. "Our experiments provide the first evidence that angiotensin-(1-7) inhibits the proliferation of human lung cancer cells," they said.

2 Aug 2004

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Hotspots in two areas of a gene that encodes a specific signaling enzyme, or kinase, are vulnerable to a variety of mutations found in five types of brain cancers, according to a report published in the August 1 issue of the journal Cancer Research.

2 Aug 2004

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Acrongenomics Inc. has introduced a revolutionary design of its nanobiotechnology product, the Neo-EpCAM(TM) cancer detection kit, which fuses molecular diagnostics with nanotechnology.

29 Jul 2004

Rapid detection of anthrax inhalation

Authors of a research letter in this week’s issue of THE LANCET outline progress in the ability to rapidly detect anthrax inhalation in the event of bioterrorist attacks.

29 Jul 2004

Influence of alcohol consumption on risk of developing hypertension and type 2 diabetes

Researchers at Wake Forest University Baptist Medical Center will seek to determine the influence of alcohol consumption on risk of developing hypertension and type 2 diabetes using data collected during a five-year study of a prediabetic condition.

29 Jul 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

Corus Pharma selected as a biotech company to watch

Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."

29 Jul 2004

Possible inherited component for lung cancer

Researchers have discovered a possible inherited component for lung cancer, a disease normally associated with external causes, such as cigarette smoking.

27 Jul 2004

New study suggests that WTC pollutants might have affected unborn babies

While public health officials reported that the air in lower Manhattan was safe to breathe, many residents suffering from symptoms such as raw throats, burning eyes, nose bleeds, and intermittent asthma attacks, were afraid, confused, and suspicious of what the authorities were telling them.

27 Jul 2004

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

A new study published July 26, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, finds a patient's symptoms and results of quality of life assessments may provide important clues to an individual patient's prognosis. Psychosocial factors, such as anxiety or spiritual distress, did not predict shorter survival.

26 Jul 2004